Julian Heslop

Julian Heslop

No más puestos en curso

Fortuna: 120 923 $ al 31/07/2026

72 años
Health Technology
Commercial Services
Consumer Non-Durables

Perfil

Julian Spenser Heslop formerly worked at ViiV Healthcare Ltd., as Chairman, Genelabs Technologies, Inc., as Chief Financial Officer & Executive Director, GSK Plc, as Chief Financial Officer & Executive Director in 2011, Dechra Pharmaceuticals Plc, as Independent Non-Executive Director from 2013 to 2022, The Royal Academy of Arts, as Director, Itaconix Plc, as Independent Non-Executive Director from 2012 to 2018, Glaxo Wellcome Plc, as Financial Controller from 1998 to 2000, Grand Metropolitan Plc, as Controller, and Stoy Hayward Ltd., as Auditor in 1979.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
0,04 %
01/11/2025 95.000 ( 0,04 % ) 69 037 $ 31/07/2026
0,03 %
01/03/2026 102.000 ( 0,03 % ) 51 886 $ 31/07/2026

Antiguos cargos conocidos de Julian Heslop.

EmpresasCargoFin
DECHRA PHARMACEUTICALS Director/Miembro de la Junta 05/09/2022
ITACONIX PLC Director/Miembro de la Junta 02/10/2018
GSK PLC Director Financiero/CFO 31/03/2011
Presidente 01/03/2011
Comptroller/Controller/Auditor 01/01/2000
Ver el detalle de la experiencia de Julian Heslop.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

71

Relaciones de 1er grado

9

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas9

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Non-Durables

Commercial Services

Commercial Services

Process Industries

Health Technology